J. A. Sparano

A randomized phase II pilot trial of adjuvant marimastat in patients with early-stage breast cancer

Kathy D. Miller, William J. Gradishar, Lynn M. Schuchter et al. · Annals of Oncology · 2002 · 63 citations · Full text

Surgical Oncology, Oncology, Breast Oncology +6

Liposomal anthracyclines for breast cancer

J. A. Sparano, EP Winer · Seminars in Oncology · 2001 · 50 citations

Breast Oncology, Breast Cancer, Tumor Targeting +4

Paclitaxel (Taxol)/doxorubicin combinations in advanced breast cancer: the Eastern Cooperative Oncology Group experience.

George W. Sledge, N. J. Robert, J. A. Sparano et al. · PubMed · 1994 · 49 citations

Genetic associations with taxane-induced neuropathy by a genome-wide association study (GWAS) in E5103.

B. P. Schneider, L. Li, Kurt W. Miller et al. · Journal of Clinical Oncology · 2011 · 44 citations

Neurogenomics, Genetics, Cancer Management +29

Phase III study of doxorubicin-cyclophosphamide followed by paclitaxel or docetaxel given every 3 weeks or weekly in operable breast cancer: Results of Intergroup Trial E1199

J. A. Sparano, M. Wang, Simona Di Martino et al. · Journal of Clinical Oncology · 2007 · 40 citations

Surgical Oncology, Oncology, Paclitaxel 175 +14